Antimicrobial-associated harm in critical care: a narrative review
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
The belief that, for the individual patient, the benefit of prompt and continued use of antimicrobials outweighs any potential harm is a significant barrier to improved stewardship of these vital agents. Antimicrobial stewardship may be perceived as utilitarian rationing, seeking to preserve the availability of effective antimicrobials by limiting the development of resistance in a manner which could conflict with the immediate treatment of the patient in need. This view does not account for the growing evidence of antimicrobial-associated harm to individual patients. This review sets out the evidence for antimicrobial-associated harm and how this should be balanced with the need for prompt and appropriate therapy in infection. It describes the mechanisms by which antimicrobials may harm patients including: mitochondrial toxicity; immune cell toxicity; adverse drug reactions; selection of resistant organisms within a given patient; and disruption of the microbiome. Finally, the article indicates how the harms of antimicrobials may be mitigated and identifies areas for research and development in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Unnecessary antibiotic use increases the risk of developing multidrug-resistant organisms and leading to serious side effects and complications, including C. difficile infection, allergic reactions, and organ toxicity [22].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [22]
In the citing paper
“The desirable effects of empiric antiviral therapy are unknown, and as for other antimicrobial agents there is a risk of undesirable effects [165].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [165]
In the citing paper
“while in patients with a low risk for MDR organisms, we suggest using a single agents for empiric treatment, as there are no apparent benefits of using two agents and the a risk of antimicrobial-associated undesirable effects, including direct toxicity, Clostridioides difficile infection and development of antibiotic resistance [165].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [165]
In the citing paper
“Antimicrobial exposure is linked to the development of antimicrobial resistance and efforts to reduce both the number of antibiotics administered and their spectrum of therapy are therefore important strategies in patients with sepsis and septic shock [165].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [165]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,641
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620
Association between mitochondrial dysfunction and severity and outcome of septic shock
Brealey, D., Brand, M., Hargreaves, I., Heales, S., Land, J., Smolenski, R., Davies, N. A., Cooper, C. E., & Singer, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09459-x · Cited by 1,503
Microbiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281 · cited 1×
“However, a note of caution is sounded by reports of both faecal microbiota transplant and probiotic therapy being implicated in bacteraemia [100, 101].”
BackgroundNew mitochondrial DNA synthesis enables NLRP3 inflammasome activation
Zhong, Z., Liang, S., Sanchez-Lopez, E., He, F., Shalapour, S., Lin, X.-J., Wong, J., Ding, S., Seki, E., Schnabl, B., et al. (2018) · Nature · doi:10.1038/s41586-018-0372-z · Cited by 1,208
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Cotten, C. M., Taylor, S., Stoll, B., Goldberg, R. N., Hansen, N. I., Sánchez, P. J., Ambalavanan, N., Benjamin, D. K., & for the NICHD Neonatal Research Network (2009) · Pediatrics · doi:10.1542/peds.2007-3423 · Cited by 974
Fagon, J.-Y., Chastre, J., Wolff, M., Gervais, C., Parer-Aubas, S., Stéphan, F., Similowski, T., Mercat, A., Diehl, J.-L., Sollet, J.-P., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-8-200004180-00004 · Cited by 854
de Jong, E., van Oers, J. A., Beishuizen, A., Vos, P., Vermeijden, W. J., Haas, L. E., Loef, B. G., Dormans, T., van Melsen, G. C., Kluiters, Y. C., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00053-0 · Cited by 836
Dickson, R. P., Singer, B. H., Newstead, M. W., Falkowski, N. R., Erb-Downward, J. R., Standiford, T. J., & Huffnagle, G. B. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.113 · Cited by 724
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis
Cheng, S.-C., Scicluna, B. P., Arts, R. J. W., Gresnigt, M. S., Lachmandas, E., Giamarellos-Bourboulis, E. J., Kox, M., Manjeri, G. R., Wagenaars, J. A. L., Cremer, O. L., et al. (2016) · Nature Immunology · doi:10.1038/ni.3398 · Cited by 637 · cited 1×
“Mitochondria are integral to regulating immune function, and defects in energy metabolism of leukocytes are associated with immunoparalysis in septic patients [41].”
BackgroundInadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized Patients
Kollef, M. H. (2000) · Clinical Infectious Diseases · doi:10.1086/314079 · Cited by 635
The role of mitochondrial dysfunction in sepsis-induced multi-organ failure
Singer, M. (2014) · Virulence · doi:10.4161/viru.26907 · Cited by 617
Blumenthal, K. G., Peter, J. G., Trubiano, J. A., & Phillips, E. J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32218-9 · Cited by 614
Oxidative stress and mitochondrial dysfunction in sepsis
Galley, H. F. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer093 · Cited by 611
Bactericidal Antibiotics Induce Mitochondrial Dysfunction and Oxidative Damage in Mammalian Cells
Kalghatgi, S., Spina, C. S., Costello, J. C., Liesa, M., Morones-Ramirez, J. R., Slomovic, S., Molina, A., Shirihai, O. S., & Collins, J. J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006055 · Cited by 563
Cammarota, G., Masucci, L., Ianiro, G., Bibbò, S., Dinoi, G., Costamagna, G., Sanguinetti, M., & Gasbarrini, A. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13144 · Cited by 558
Harper, N. J. N., Cook, T. M., Garcez, T., Farmer, L., Floss, K., Marinho, S., Torevell, H., Warner, A., Ferguson, K., Hitchman, J., et al. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.04.014 · Cited by 520
A Randomized Trial of Diagnostic Techniques for Ventilator-Associated Pneumonia
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa052904 · Cited by 491
The impact of a reported penicillin allergy on surgical site infection risk.
Blumenthal, K. G., Ryan, E. E., Li, Y., Lee, H., Kuhlen, J. L., & Shenoy, E. S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix794 · Cited by 481
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
Gadsby, N. J., Russell, C. D., McHugh, M. P., Mark, H., Conway Morris, A., Laurenson, I. F., Hill, A. T., & Templeton, K. E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1214 · Cited by 446
Survival in Critical Illness Is Associated with Early Activation of Mitochondrial Biogenesis
Carré, J. E., Orban, J.-C., Re, L., Felsmann, K., Iffert, W., Bauer, M., Suliman, H. B., Piantadosi, C. A., Mayhew, T. M., Breen, P., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0326oc · Cited by 441
Tabah, A., Koulenti, D., Laupland, K., Misset, B., Valles, J., Bruzzi de Carvalho, F., Paiva, J. A., Çakar, N., Ma, X., Eggimann, P., et al. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2695-9 · Cited by 436
Self-citationExtreme Dysbiosis of the Microbiome in Critical Illness
McDonald, D., Ackermann, G., Khailova, L., Baird, C., Heyland, D., Kozar, R., Lemieux, M., Derenski, K., King, J., Vis-Kampen, C., et al. (2016) · mSphere · doi:10.1128/msphere.00199-16 · Cited by 426
Karanika, S., Paudel, S., Grigoras, C., Kalbasi, A., & Mylonakis, E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-16 · Cited by 402
The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex
Dröse, S., & Brandt, U. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803236200 · Cited by 386
Zaborin, A., Smith, D., Garfield, K., Quensen, J., Shakhsheer, B., Kade, M., Tirrell, M., Tiedje, J., Gilbert, J. A., Zaborina, O., et al. (2014) · mBio · doi:10.1128/mbio.01361-14 · Cited by 367
Derde, L. P. G., Cooper, B. S., Goossens, H., Malhotra-Kumar, S., Willems, R. J. L., Gniadkowski, M., Hryniewicz, W., Empel, J., Dautzenberg, M. J. D., Annane, D., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70295-0 · Cited by 356
RUIZ, M., TORRES, A., EWIG, S., MARCOS, M. A., ALCÓN, A., LLEDÓ, R., ASENJO, M. A., & MALDONALDO, A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.1.9907090 · Cited by 340
Gut dysbiosis impairs recovery after spinal cord injury
Kigerl, K. A., Hall, J. C. E., Wang, L., Mo, X., Yu, Z., & Popovich, P. G. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151345 · Cited by 339
Kelly, B., Tannahill, G. M., Murphy, M. P., & O'Neill, L. A. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662114 · Cited by 334
EWIG, S., TORRES, A., EL-EBIARY, M., FÀBREGAS, N., HERNÁNDEZ, C., GONZÁLEZ, J., NICOLÁS, J. M., & SOTO, L. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9803097 · Cited by 331
Yelin, I., Flett, K. B., Merakou, C., Mehrotra, P., Stam, J., Snesrud, E., Hinkle, M., Lesho, E., McGann, P., McAdam, A. J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0626-9 · Cited by 315
Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense
Garaude, J., Acín-Pérez, R., Martínez-Cano, S., Enamorado, M., Ugolini, M., Nistal-Villán, E., Hervás-Stubbs, S., Pelegrín, P., Sander, L. E., Enríquez, J. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3509 · Cited by 313
Role of Oxidative Stress and Mitochondrial Dysfunction in Sepsis and Potential Therapies
Mantzarlis, K., Tsolaki, V., & Zakynthinos, E. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5985209 · Cited by 311
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
Armand-Lefèvre, L., Angebault, C., Barbier, F., Hamelet, E., Defrance, G., Ruppé, E., Bronchard, R., Lepeule, R., Lucet, J.-C., El Mniai, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01823-12 · Cited by 300
Uranga, A., España, P. P., Bilbao, A., Quintana, J. M., Arriaga, I., Intxausti, M., Lobo, J. L., Tomás, L., Camino, J., Nuñez, J., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.3633 · Cited by 290
Antibiotic-associated encephalopathy
Bhattacharyya, S., Darby, R. R., Raibagkar, P., Gonzalez Castro, L. N., & Berkowitz, A. L. (2016) · Neurology · doi:10.1212/wnl.0000000000002455 · Cited by 284
Lankelma, J. M., van Vught, L. A., Belzer, C., Schultz, M. J., van der Poll, T., de Vos, W. M., & Wiersinga, W. J. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4613-z · Cited by 283
A Randomized Trial of Diagnostic Techniques for Ventilator-Associated Pneumonia
Barker, J. A. (2008) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)79233-2 · Cited by 281
The antibiotic course has had its day
Llewelyn, M. J., Fitzpatrick, J. M., Darwin, E., SarahTonkin-Crine, Gorton, C., Paul, J., Peto, T. E. A., Yardley, L., Hopkins, S., & Walker, A. S. (2017) · BMJ · doi:10.1136/bmj.j3418 · Cited by 269
Yang, J. H., Bhargava, P., McCloskey, D., Mao, N., Palsson, B. O., & Collins, J. J. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.020 · Cited by 267
Leone, M., Bechis, C., Baumstarck, K., Lefrant, J.-Y., Albanèse, J., Jaber, S., Lepape, A., Constantin, J.-M., Papazian, L., Bruder, N., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3411-8 · Cited by 243
Bloos, F., Thomas-Rüddel, D., Rüddel, H., Engel, C., Schwarzkopf, D., Marshall, J. C., Harbarth, S., Simon, P., Riessen, R., Keh, D., et al. (2014) · Critical Care · doi:10.1186/cc13755 · Cited by 240
Kett, D. H., Cano, E., Quartin, A. A., Mangino, J. E., Zervos, M. J., Peyrani, P., Cely, C. M., Ford, K. D., Scerpella, E. G., & Ramirez, J. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70314-5 · Cited by 235
Martínez-García, J. J., Martínez-Banaclocha, H., Angosto-Bazarra, D., de Torre-Minguela, C., Baroja-Mazo, A., Alarcón-Vila, C., Martínez-Alarcón, L., Amores-Iniesta, J., Martín-Sánchez, F., Ercole, G. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10626-x · Cited by 233
Reducing ventilator-associated pneumonia in intensive care: Impact of implementing a care bundle*
Morris, A. C., Hay, A. W., Swann, D. G., Everingham, K., McCulloch, C., McNulty, J., Brooks, O., Laurenson, I. F., Cook, B., & Walsh, T. S. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182227d52 · Cited by 232
Hranjec, T., Rosenberger, L. H., Swenson, B., Metzger, R., Flohr, T. R., Politano, A. D., Riccio, L. M., Popovsky, K. A., & Sawyer, R. G. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70151-2 · Cited by 231
Tackling antimicrobial resistance 2019–2024 – The UK's five-year national action plan
Courtenay, M., Castro-Sanchez, E., Fitzpatrick, M., Gallagher, R., Lim, R., & Morris, G. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.02.019 · Cited by 229
Neidell, M. J., Cohen, B., Furuya, Y., Hill, J., Jeon, C. Y., Glied, S., & Larson, E. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis552 · Cited by 223
Duewelhenke, N., Krut, O., & Eysel, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00729-05 · Cited by 215
Kollef, M. H., Chastre, J., Clavel, M., Restrepo, M. I., Michiels, B., Kaniga, K., Cirillo, I., Kimko, H., & Redman, R. (2012) · Critical Care · doi:10.1186/cc11862 · Cited by 208
for the MEDUSA study group, Bloos, F., Rüddel, H., Thomas-Rüddel, D., Schwarzkopf, D., Pausch, C., Harbarth, S., Schreiber, T., Gründling, M., Marshall, J., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4782-4 · Cited by 200
Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
Saltzman, E. T., Palacios, T., Thomsen, M., & Vitetta, L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00061 · Cited by 193
Wachter, R. M., Flanders, S. A., Fee, C., & Pronovost, P. J. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-1-200807010-00007 · Cited by 180
Zakharkina, T., Martin-Loeches, I., Matamoros, S., Povoa, P., Torres, A., Kastelijn, J. B., Hofstra, J. J., de Wever, B., de Jong, M., Schultz, M. J., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209158 · Cited by 180
Antibiotic Adverse Reactions and Drug Interactions
Granowitz, E. V., & Brown, R. B. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.12.011 · Cited by 177
Trouillet, J. L., Vuagnat, A., Combes, A., Kassis, N., Chastre, J., & Gibert, C. (2002) · Clinical Infectious Diseases · doi:10.1086/339488 · Cited by 176
One Codex: A Sensitive and Accurate Data Platform for Genomic Microbial Identification
Minot, S. S., Krumm, N., & Greenfield, N. B. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/027607 · Cited by 164
Effect of antibiotics on the immune response
Hauser, W. E., & Remington, J. S. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90534-4 · Cited by 163
Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness
Wischmeyer, P. E., McDonald, D., & Knight, R. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000321 · Cited by 159
Therapeutic drug monitoring of anti-infective agents in critically ill patients
Jager, N. G. L., van Hest, R. M., Lipman, J., Taccone, F. S., & Roberts, J. A. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1172209 · Cited by 134
Self-citationCell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study
Morris, A. C., Datta, D., Shankar‐Hari, M., Stephen, J., Weir, C. J., Rennie, J., Antonelli, J., Bateman, A. P., Warner, N. L., Judge, K. W., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5247-0 · Cited by 133
Capellier, G., Mockly-Postal, H., Charpentier, C., Annane, D., Blasco, G., Desmettre, T., Roch, A., Faisy, C., Cousson, J., Limat, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041290 · Cited by 132
Johanesen, P., Mackin, K. E., Hutton, M. L., Awad, M. M., Larcombe, S., Amy, J., & Lyras, D. (2015) · Genes · doi:10.3390/genes6041347 · Cited by 130
Marchaim, D., Chopra, T., Bhargava, A., Bogan, C., Dhar, S., Hayakawa, K., Pogue, J. M., Bheemreddy, S., Blunden, C. E., Shango, M. M., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/666642 · Cited by 128
Human microbiomes and antibiotic resistance
Baron, S. A., Diene, S. M., & Rolain, J.-M. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.08.005 · Cited by 128
Hellyer, T. P., McAuley, D. F., Walsh, T. S., Anderson, N., Morris, A. C., Singh, S., Dark, P. M., Roy, A. I., Perkins, G. D., McMullan, R., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30367-4 · Cited by 127
Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients
Ravi, A., Halstead, F. D., Bamford, A., Casey, A., Thomson, N. M., van Schaik, W., Snelson, C., Goulden, R., Foster-Nyarko, E., Savva, G. M., et al. (2019) · Microbial Genomics · doi:10.1099/mgen.0.000293 · Cited by 125
Staley, C. M., Kelly, C. R., Brandt, L. J., Khoruts, A., & Sadowsky, M. J. (2016) · mBio · doi:10.1128/mbio.01965-16 · Cited by 116
Improving sepsis treatment by embracing diagnostic uncertainty.
Prescott, H. C., & Iwashyna, T. J. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201809-646ps · Cited by 110
Pettigrew, M. M., Gent, J. F., Kong, Y., Halpin, A. L., Pineles, L. L., Harris, A. D., & Johnson, J. K. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy936 · Cited by 108
Robak, O. H., Heimesaat, M. M., Kruglov, A. A., Prepens, S., Ninnemann, J., Gutbier, B., Reppe, K., Hochrein, H., Suter, M., Kirschning, C. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97065 · Cited by 105
Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells.
Lawrence, J. W., Claire, D., Weissig, V., & Rowe, T. C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09546-x · Cited by 104
Manzanares, W., Lemieux, M., Elke, G., Langlois, P. L., Bloos, F., & Heyland, D. K. (2016) · Critical Care · doi:10.1186/s13054-016-1529-5 · Cited by 100
Dysbiosis Across Multiple Body Sites in Critically Ill Adult Surgical Patients
Yeh, A., Rogers, M. B., Firek, B., Neal, M. D., Zuckerbraun, B. S., & Morowitz, M. J. (2016) · Shock · doi:10.1097/shk.0000000000000691 · Cited by 98
Raman, K., Nailor, M. D., Nicolau, D. P., Aslanzadeh, J., Nadeau, M., & Kuti, J. L. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318287f713 · Cited by 91
Early source control in sepsis
Waele, J. J. D. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0650-1 · Cited by 72
Weng, H., Li, J., Mao, Z., Feng, Y., Wang, X., Ren, X., & Zeng, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00717 · Cited by 69
Ang, H., & Sun, X. (2018) · International Journal of Nursing Practice · doi:10.1111/ijn.12644 · Cited by 53
An Algorithm to Estimate the Importance of Bacterial Acquisition Routes in Hospital Settings
Bootsma, M., Bonten, M. J. M., Nijssen, S., Fluit, A. C., & Diekmann, O. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm149 · Cited by 47
Onakpoya, I., Walker, A. S., Tan, P. S., Spencer, E. A., Gbinigie, O. A., Cook, J., Llewelyn, M., & Butler, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194858 · Cited by 42
Cornett, E. M., Novitch, M. B., Kaye, A. D., Pann, C. A., Bangalore, H. S., Allred, G., Bral, M., Jhita, P. K., & Kaye, A. M. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1362938 · Cited by 39
What are the Evolutionary Origins of Mitochondria? A Complex Network Approach
de Carvalho, D. S., Andrade, R. F. S., Pinho, S. T. R., Goés‐Neto, A., Lobão, T. C. P., Bomfim, G. C., & El-Hani, C. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134988 · Cited by 31
Invasive Candida Infections in the ICU: Diagnosis and Therapy
Hankovszky, P., Társy, D., Öveges, N., & Molnár, Z. (2015) · The Journal of Critical Care Medicine · doi:10.1515/jccm-2015-0025 · Cited by 31
Shu, C.-C., Wang, D., Guo, J., Song, J., Chen, S., Chen, L., & Gao, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00307 · Cited by 30
The renal mitochondrial toxicity of beta-lactam antibiotics
Tune, B. M., & Hsu, C. Y. (1990) · Journal of the American Society of Nephrology · doi:10.1681/asn.v15815 · Cited by 24
Allergic and hypersensitivity reactions in the intensive care unit
Kanji, S., & Chant, C. A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181de0c99 · Cited by 24
Critical illness and the role of the microbiome
Otani, S., Chihade, D. B., & Coopersmith, C. M. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.383 · Cited by 22
Scawn, N. D. A., Saul, D., Pathak, D., Matata, B. M., Kemp, I., Stables, R., Lane, S., Haycox, A. R., & Houten, R. (2012) · Health Technology Assessment · doi:10.3310/hta16360 · Cited by 20
Apellaniz, G., Valdés, M., Pérez, R., Martin, F., Soria, F., García, A. O., Gòmez, J., & Vicente, T. (1991) · Journal of Chemotherapy · doi:10.1080/1120009x.1991.11739072 · Cited by 19
Use of probiotics to prevent ventilator-associated pneumonia: A survey of pharmacists' attitudes
Wheeler, K. E., Cook, D. J., Mehta, S., Calce, A., Guenette, M. D., Perreault, M. M., Thiboutot, Z., Duffett, M., & Burry, L. D. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.10.016 · Cited by 13
Microbiota in ICU, not only a gut problem
Alagna, L., Bandera, A., Patruno, A., Muscatello, A., Citerio, G., & Gori, A. (2019) · Intensive Care Medicine · doi:10.1007/s00134-018-05516-7 · Cited by 6
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Ventilator-associated pneumonia in critically ill patients with COVID-19
Maes, M., Higginson, E., Pereira-Dias, J., Curran, M. D., Parmar, S., Khokhar, F., Cuchet-Lourenço, D., Lux, J., Sharma-Hajela, S., Ravenhill, B., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03460-5 · Cited by 312
Wang, B., Xu, Z., & Dong, B. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.133925 · Cited by 239
Fernando, S. M., Tran, A., Cheng, W., Klompas, M., Kyeremanteng, K., Mehta, S., English, S. W., Muscedere, J., Cook, D. J., Torres, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06036-z · Cited by 231
Metadata
- Authors
- Arulkumaran, N., Routledge, M., Schlebusch, S., Lipman, J., & Conway Morris, A.
- Affiliations
- University College London (GB)
- University of Cambridge (GB)
- Queensland Health (AU)
- The University of Queensland (AU)
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2020-01-29
- Volume
- 46
- Issue
- 2
- Pages
- 225-235
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- PMC
- PMC7046486
- OpenAlex
- W3004103291
- Cited by
- 175
- References
- 103
- Citations by year
- 2026: 25 · 2025: 35 · 2024: 37 · 2023: 22 · 2022: 28 · 2021: 20 · 2020: 8
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (WT 2055214/Z/16/Z)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial stewardship, intensive care, mitochondrial toxicity, adverse drug reactions, antimicrobial resistance, intensive care unit infections, harm mitigation
- MeSH terms
- Medical Overuse, Antimicrobial Stewardship, Anti-Infective Agents, Critical Care, Humans, Time Factors, Microbiota, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.